TSUMURA + CO.

View in Terminal

Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

There is currently no news available for this company. We are working on adding more providers to change this.

Historical dividends Dividends

All dividend metrics All metrics

In 2026, TSUMURA + CO. has already paid €0.43 in dividends. The last payout was in June.

Financials

In the last quarter, TSUMURA + CO. had revenue of €267.77m and net profit of €34.79m

(EUR)	June 2026	YoY
Revenue	267.77m	5.32%
Gross profit	121.74m	0.57%
Net profit	34.79m	35.04%
EBITDA	62.39m	14.18%

Fundamentals

Metric	Value
Market capitalization	€1.6bn
Number of shares	74.55m
52-week high/low	€24.74 - €19.74
Dividend yield	3.72%
Dividends TTM	€0.80
Beta	0.07
P/E ratio	9.40
PEG ratio	0.47
P/B ratio	0.87
P/S ratio	1.42

Company profile

Tsumura & Co. engages in the manufacture and sale of pharmaceutical products worldwide. The company offers Kampo extract intermediates and granular Kampo formulations. It is involved in the procurement, selection and processing, and storage of raw material crude drugs and crude drug pieces for decoction; manufacture of Kampo powdered extracts and traditional Chinese medicines; and sale of pharmaceuticals and food products. The company was founded in 1893 and is headquartered in Tokyo, Japan.